The Human Microbiota in Endocrinology: Implications for Pathophysiology, Treatment, and Prognosis in Thyroid Diseases

Front Endocrinol (Lausanne). 2020 Dec 4:11:586529. doi: 10.3389/fendo.2020.586529. eCollection 2020.

Abstract

The human microbiota is an integral component in the maintenance of health and of the immune system. Microbiome-wide association studies have found numerous diseases associated to dysbiosis. Studies are needed to move beyond correlations and begin to address causation. Autoimmune thyroid diseases (ATD) are one of the most common organ-specific autoimmune disorders with an increasing prevalence, higher than 5% worldwide. Most frequent manifestations of ATD are Hashimoto's thyroiditis and Graves' disease. The exact etiology of ATD remains unknown. Until now it is not clear whether bacterial infections can trigger ATD or modulate the efficacy of treatment and prognosis. The aim of our review is to characterize the microbiota and in ATD and to evaluate the impact of dysbiosis on treatment and prognosis. Moreover, variation of gut microbiome has been associated with thyroid cancer and benign nodules. Here we will characterize the microbioma in benign thyroid nodules, and papillary thyroid cancer to evaluate their implications in the pathophysiology and progression.

Keywords: Hashimoto autoimmune thyroiditis; autoimmunity; cancer; gut microbiota; thyroid.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoimmunity
  • Dysbiosis / immunology
  • Dysbiosis / microbiology
  • Endocrine System / immunology
  • Endocrine System / microbiology
  • Gastrointestinal Microbiome / immunology*
  • Graves Disease / epidemiology
  • Graves Disease / immunology
  • Graves Disease / microbiology*
  • Hashimoto Disease / epidemiology
  • Hashimoto Disease / immunology
  • Hashimoto Disease / microbiology*
  • Humans
  • Prognosis
  • Thyroid Cancer, Papillary / microbiology*
  • Thyroid Neoplasms / microbiology*